Also found in: Medical.
CVVHDContinuous Venovenous Hemodialysis
CVVHDContinuous Venous to Venous Hemodialysis
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Uptodate[R] Piperasilin- CVVH: 2,25-3,375 g q8h Tazobaktam CVVHD: 2,25-3,37 g q6h CVVHDF: 3,375 g q6h Trimetoprim/ TMP 2,5-7,5 mg/kg Sulfametoksazol q12h PJP ile enfekte kritik CVVHDF hastalarinda dozu q12h 10 mg/kg'a yukseltmek gerekebilir.
Similar to our findings, 2 studies have reported that standard liver-function parameters show poor predictive capabilities regarding citrate accumulation in patients with cirrhosis and in patients with liver failure and AKI who received CVVHD [9, 29].
aPTT: Activated partial thromboplastin time ARF: Acute renal failure BUN: Blood urea nitrogen CRRT: Continuous renal replacement therapy CVVHD: Continuous venovenous haemodialysis CVVHDF: Continuous venovenous haemodiafiltration HIT: Heparin induced thrombocytopenia ICU: Intensive care unit RRT: Renal replacement therapy SAPS II: Simplified acute physiology score II SOFA: Sequential organ failure assessment U: Unit.
In case of CVVHD anticoagulation strategy resulted in significant different filter life spans; that is, RAC resulted in a median filter lifetime of 32 hours, while heparin anticoagulation led to a median filter lifetime of 18 hours, argatroban to 14 hours, and abandonment of any anticoagulation to 8 hours, respectively (log-rank test P = 0.001; see Figure 1).
Continuous veno venous haemodialysis (CVVHD) works on the principle of dialysis and ultra filtration.
Acute renal failure: CVVHD Patient ECMO complications Outcome 1 Cannula migration: Died day 24: multi- repositioned organ failure and sepsis 2 Discharged home day 40.
Ventilator, Intraaortic balloon pump (IABP), Left ventricular assistive device (LVAD), Continuous venovenous hemodialysis (CVVHD).
Although physical therapists frequently work in the intensive care unit, ambulating patients with a left ventricular assist device (LVAD) and continuous veno venous hemodialysis (CVVHD) is rare.
We recently observed a patient who developed profound hypercalcemia while undergoing continuous veno-venous hemofiltration dialysis (CVVHD).
We performed a combined treatment of hemoadsorption using a Cytosorb hemoadsorber (CytoSorb; Cytosorbents GmbH, Berlin, Germany) and continuous venovenous hemodialysis (CVVHD) (Multifiltrate, Fresenius Medical Care) while the patient had to be mechanically ventilated suffering from acute respiratory distress syndrome.